Medgenics, the company that has developed a novel technology for the manufacture and delivery of therapeutic proteins continuously in patients using their own tissue, is delighted to announce the appointment to the Company's Strategic Advisory Board of Dr. Stephen Ettinger, a world-renowned expert in veterinary medicine, who has held senior lecturing positions in many top universities and had over 150 books and papers published, with over 40 years of experience. Among his many honours and committee recognitions, Dr. Ettinger sits on the Board of Trustees at Cornell University and holds memberships at the California Veterinary Medical Association, the American College of Cardiology and the American Heart Association. Dr. Ettinger's appointment reflects the Company's decision to expand its Strategic Advisory Board to include members possessing a wider range of professional and commercial skills that will be required going forward, and to explore new directions and strategies for its Biopump technology.
Keywords : American College of Cardiology American Heart Association California Veterinary Medical Association Cornell University Medgenics Stephen Ettinger
Reader comments (0)